超越成人标准:儿童淋巴结细胞病理学WHO报告系统的适配与临床应用
该研究探讨WHO淋巴结、脾和胸腺细胞病理学报告系统在儿童人群中的适用性与临床效用,提出以细针穿刺活检为核心的儿童诊断路径,强调多学科整合。研究发现儿童良性类别常包含模仿恶性的旺盛免疫母细胞增殖,非典型和可疑类别的恶性风险受恶性肿瘤罕见性显著影响,建议在可疑和恶性类别中采用快速现场评估(ROSE)以即时过渡到辅助检测和临床分期。
要点
- 儿童应用WHO系统需调整解释阈值,单调小细胞群在儿童多代表反应性过程或侵袭性小圆蓝细胞肿瘤。
- 良性类别需注意旺盛免疫母细胞增殖(如EB病毒)可模仿恶性。
- 可疑和恶性类别在最佳条件下使用ROSE可即时过渡到辅助检测和临床分期。
核心结论
- WHO系统在结合儿童特异性生物学参数后是儿童评估的稳健工具。
- 整合ROSE和介入病理学可减少侵入性操作并加速危及生命恶性肿瘤的治疗时间。
研究设计与样本
- 研究提出以细针穿刺活检为核心的儿童诊断路径,按WHO系统既定方案实施,强调多学科方法整合。
主要发现
- 儿童良性类别常包括模仿恶性的旺盛免疫母细胞增殖(如EB病毒)。
- 非典型和可疑类别为关键灰色地带,其恶性风险受恶性肿瘤罕见性显著影响。
- 儿童单调小细胞群通常代表反应性过程或侵袭性小圆蓝细胞肿瘤,而在成人可能提示低级别B细胞淋巴瘤。
- 介入病理学家在降低非诊断率中至关重要。
关键数值与推荐
- WHO系统提供标准化五分类框架以增强诊断一致性。
临床怎么用
- 儿童应用需调整解释阈值,结合儿童特异性鉴别诊断评估五分类。
- 对可疑和恶性类别,在最佳条件下使用ROSE可即时过渡到辅助检测和临床分期。
- 恶性或可疑诊断应触发立即多学科干预以预防并发症。
- 介入病理学家参与有助于降低非诊断率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization (WHO) Reporting System for Lymph Node, Spleen, and Thymus Cytopathology (WHO System) offers a standardized five-category framework to enhance diagnostic consistency. Although globally applicable, its risk of malignancy (ROM) and management protocols are largely generalized. This study explores the system's specific applicability and clinical utility within the pediatric population. METHODS: The study presents a pediatric diagnostic pathway centered on fine-needle aspiration biopsy, implemented according to the protocols established by the WHO System. The methodology emphasizes the integration of a multidisciplinary approach. The five WHO categories are evaluated through the lens of pediatric-specific differential diagnoses. RESULTS: In pediatric practice, the Benign category often includes exuberant immunoblastic proliferation (e.g., Epstein-Barr virus) that mimics malignancy. Atypical and Suspicious categories represent a critical "gray zone" where the ROM is significantly influenced by the rarity of malignancy. Findings suggest that for Suspicious and Malignant categories, the use of rapid on-site evaluation (ROSE) under optimal conditions allows for an immediate transition to ancillary testing and clinical staging. DISCUSSION: Pediatric application requires shifted interpretive thresholds. Monotonous small cell populations, which might suggest low-grade B-cell lymphoma in adults, typically represent reactive processes or aggressive small round blue cell tumors in children. The interventional pathologist is vital in reducing "non-diagnostic" rates. Furthermore, a "malignant" or "suspicious" diagnosis should trigger immediate multidisciplinary intervention to prevent complications. CONCLUSION: The WHO System is a robust tool for pediatric evaluation when contextualized within pediatric-specific biological parameters. Integrating ROSE and interventional pathology minimizes invasive procedures and accelerates time-to-treatment for life-threatening malignancies.
引用
- Barroca H, Schmitt F. Beyond the adult standard: Tailoring the WHO Reporting System for Lymph Node Cytopathology to pediatric diagnostics and management. Cancer Cytopathol. 2026. PMID: 42018429. doi:10.1002/cncy.70095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。